Fundraising Fox
🦊/Companies
Sign in

Adagene

NASDAQ: ADAG

Founded 2012 · Incorporated in Cayman Islands · 82 employees on LinkedIn · 4 known investors

Find your way into Adagene

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.

AI & Machine LearningBiotech

Investors · 4

Eight Roads VenturesMumbai · $5M – $30M
F-Prime CapitalCambridge · $3M – $10M
Toba CapitalIrvine · $1M – $10M
General AtlanticreportedNew York · $10M – $1B

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 6

by search overlap
enGene38 shared keywordsenGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Enzene Biosciences Ltd22 shared keywordsEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
Antengene19 shared keywordsAntengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
Origene19 shared keywordsOriGene develops and supplies genomic and proteomic research tools, including proteins and antibodies built on its proprietary cDNA clone collections, for life science researchers. The company offers a broad catalog of research products used in scientific discovery and diagnostics development.
Thumbnail for Seragon Pharmaceuticals15 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Clementia14 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.

Companies competing with Adagene for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Guggenheim reiterates Adagene stock Buy rating on competitor shift By Investing.comza.investing.com · Jul 2026Guggenheim raises Adagene stock price target on cancer drug data By Investing.cominvesting.com · Apr 2026Adagene's $70M Raise Fuels Pipeline Hopes—But Is the Bull Case Already Priced In?ainvest.com · Apr 2026Adagene Announces $70M Public Offering of ADSs - Boston Todaynationaltoday.com · Apr 2026Adagene Completes $69 Million Series D Financing Led by Growth Investor General Atlantic | General Atlanticgeneralatlantic.com · Jan 2020Adagene Raises $50 Million in Series C Fundingprnewswire.com · Mar 2018

Frequently asked questions

What does Adagene do?
Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
Who are Adagene's investors?
Adagene's investors include Eight Roads Ventures, F-Prime Capital, Toba Capital, General Atlantic.